RA

Rajaram Anantharamanan

Active Director Director DIN 09031926
DIN 09031926 First appointment Jan 2021 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajaram Anantharamanan

Data last updated:

Rajaram Anantharamanan is a Director at Crannium Health Ai Private Limited (since 2021). The company operates in Information Technology.

DIN 09031926
Primary Designation Director
Industry Information Technology
First Appointment 15 Jan 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Crannium Health Ai Private Limited U72900KA2021PTC143190
Director15 Jan 20212021Active

Board colleagues of Rajaram Anantharamanan

Directorship timeline

Open interactive timeline →
Crannium Health Ai Private Limited
Premium access

Shareholding and investment profile for Rajaram Anantharamanan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajaram Anantharamanan

Rajaram Anantharamanan currently holds 1 directorship: Crannium Health Ai Private Limited (Director, since 15 Jan 2021).

Rajaram Anantharamanan was first appointed on 15 Jan 2021 as Director at Crannium Health Ai Private Limited.

The current boards of Rajaram Anantharamanan's companies include Pranav Vajapeyam (Crannium Health Ai Private Limited), Ranga Raju Rajesh Kumar (Crannium Health Ai Private Limited), Raveesh Nandakumar (Crannium Health Ai Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available